+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endoscopic Submucosal Dissection Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • November 2023
  • Region: Global
  • Expert Market Research
  • ID: 5910824
The global endoscopic submucosal dissection market size was valued at USD 324.7 million in 2023, driven by its increasing acceptance as a pivotal technique in treating early-stage gastrointestinal cancers across the globe. The market size is anticipated to grow at a CAGR of 7.0% during the forecast period of 2024-2032 to achieve a value of USD 594.5 million by 2032.

Endoscopic Submucosal Dissection: Introduction

Endoscopic Submucosal Dissection (ESD) is a sophisticated endoscopic procedure developed primarily in Asia, aiming to remove gastrointestinal neoplasms in one piece, ensuring clear histological assessment. Unlike traditional endoscopic mucosal resection, which is suitable for smaller lesions, ESD allows for the en bloc resection of larger lesions without size restrictions.

By making a circumferential incision around the lesion and dissecting the submucosal layer beneath it, ESD ensures minimal damage to the surrounding healthy tissue. This technique has gained significant traction for its ability to treat early gastrointestinal cancers, particularly those in the stomach, oesophagus, and colon, with a lower risk of recurrence. Its minimally invasive nature, reduced hospitalization times, and potential to spare patients from more extensive surgeries make ESD a preferred choice in appropriate clinical scenarios. However, it demands advanced endoscopic skills and expertise, given its technical complexity and risk of potential complications.

Key Trends in the Global Endoscopic Submucosal Dissection Market

The global endoscopic submucosal dissection (ESD) market is being sculpted by several influential trends. Foremost is the expanding adoption of ESD as a primary intervention for early-stage gastrointestinal cancers, fueled by its superior efficacy in enabling en bloc resections and reducing recurrence rates. This is complemented by technological advancements in endoscopic tools and devices, enhancing precision and safety during procedures.

As the demand for minimally invasive surgeries swells, the preference for ESD over more invasive surgical options is palpable, leading to shorter hospital stays and improved patient recovery profiles. Training and education have surged as pivotal focal points, with medical institutions and device manufacturers investing in programs to upskill endoscopists, addressing the procedure's technical challenges. However, the market's growth is juxtaposed with concerns about procedure-related complications, emphasizing the continuous refinement of techniques and tools. In essence, the global ESD market is defined by its commitment to innovation, skill development, and the overarching goal of elevating patient outcomes in gastrointestinal oncology.

Global Endoscopic Submucosal Dissection Market Segmentation

Market Breakup by Type

  • Grasp
  • Clips
  • Gastroscopes
  • Colonoscopes

Market Breakup by Indications

  • Stomach Cancer
  • Colon Cancer

Market Breakup by End User

  • Hospitals,
  • Ambulatory Surgical Centres
  • Specialty Clinics

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Endoscopic Submucosal Dissection Market Overview

The global endoscopic submucosal dissection (ESD) market is witnessing a robust expansion, driven by its increasing acceptance as a pivotal technique in treating early-stage gastrointestinal cancers. As the medical community becomes more acquainted with the benefits of en bloc resections offered by ESD, particularly in reducing recurrence rates, its preference over traditional methods is on the rise. Technological advancements play a cardinal role, with state-of-the-art endoscopic devices being introduced to improve the precision, safety, and overall efficacy of the procedure. However, the market's trajectory isn't devoid of challenges.

The technical complexity of ESD necessitates advanced training and expertise, leading to a surge in dedicated training programs and workshops worldwide. This emphasis on skill development ensures that the benefits of the procedure are harnessed while minimizing potential complications. In summation, the global ESD market, thriving on innovation and education, is steadily establishing itself as a cornerstone in minimally invasive gastrointestinal oncology interventions.

Global Endoscopic Submucosal Dissection Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Olympus Corporation
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • T Sumitomo Bakelite Co., Ltd.
  • Creo Medical
  • Medtronic plc
  • HOYA Corporation
  • Ovesco Endoscope AG
  • ConMed Corporation
  • A Steris PLC
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Endoscopic Submucosal Dissection Market Overview
3.1 Global Endoscopic Submucosal Dissection Market Historical Value (2017-2023)
3.2 Global Endoscopic Submucosal Dissection Market Forecast Value (2024-2032)
4 Global Endoscopic Submucosal Dissection Market Landscape
4.1 Global Endoscopic Submucosal Dissection: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Endoscopic Submucosal Dissection: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indications
5 Global Endoscopic Submucosal Dissection Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Endoscopic Submucosal Dissection Market Segmentation
6.1 Global Endoscopic Submucosal Dissection Market by Type
6.1.1 Market Overview
6.1.2 Grasp
6.1.3 Clips
6.1.4 Gastroscopes
6.1.5 Colonoscopes
6.2 Global Endoscopic Submucosal Dissection Market by Indications
6.2.1 Market Overview
6.2.2 Stomach Cancer
6.2.3 Colon Cancer
6.3 Global Endoscopic Submucosal Dissection Market by End User
6.3.1 Market Overview
6.3.2 Hospitals,
6.3.3 Ambulatory Surgical Centres
6.3.4 Speciality Clinics
6.4 Global Endoscopic Submucosal Dissection Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Endoscopic Submucosal Dissection Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Endoscopic Submucosal Dissection Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Endoscopic Submucosal Dissection Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Endoscopic Submucosal Dissection Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Endoscopic Submucosal Dissection Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Supplier Landscape
15.1 Olympus Corporation
15.1.1 Financial Analysis
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 Boston Scientific Corporation
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 FUJIFILM Holdings Corporation
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 T Sumitomo Bakelite Co., Ltd.
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Creo Medical
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Medtronic plc
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 HOYA Corporation
15.7.1 Product Portfolio
15.7.2 Demographic Reach and Achievements
15.7.3 Mergers and Acquisitions
15.7.4 Certifications
15.8 Ovesco Endoscope AG
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 ConMed Corporation
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 A Steris PLC
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
18.3 Out-of-Pocket

Companies Mentioned

  • Olympus Corporation
  • Boston Scientific Corporation FUJIFILM Holdings Corporation
  • T Sumitomo Bakelite Co. Ltd.
  • Creo Medical
  • Medtronic plc
  • HOYA Corporation
  • Ovesco Endoscope AG
  • ConMed Corporation
  • A Steris PLC

Methodology

Loading
LOADING...